Breast Cancer Outcomes From Ductal Carcinoma In Situ: A Population‐Based Cohort Study
International Journal of Cancer · 15.10.2026 · 159 (8) · 1917-1927
DOI: 10.1002/ijc.70559 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Cancer, online erschienen am 20.05.2026. Verfasst von Qian Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Carcinoma, Intraductal, Noninfiltrating, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Auckland Medical Research Foundation, University of Auckland Research Development Fund.
Abstract (Originalsprache)
This population‐based cohort study investigated whether the subsequent risk of breast cancer after ductal carcinoma in situ (DCIS) has changed over time in New Zealand women diagnosed between 2000 and 2022, using data from the New Zealand Breast Cancer Foundation National Register. The primary outcome was ipsilateral breast event, including invasive cancer (iIBC) or DCIS (iDCIS). Fine‐Gray subdistributional hazard models assessed associations with demographic and clinical factors, and a 5‐year landmark analysis evaluated subsequent risk among women who remained event‐free at 5 years. Among 5830 patients (median follow‐up 4.8 years), the overall 5‐year cumulative risk of iIBC was 3.3% (95% CI: 2.7%, 3.9%). In the 5‐year landmark cohort, the subsequent 5‐year risk was 4.1% (3.3%, 5.0%). Corresponding iDCIS rates were 2.5% (2.0%, 3.0%) and 1.7% (1.2%, 2.3%), respectively. Age < 45 years at diagnosis and DCIS size > 20 mm were associated with a higher iIBC risk, but the association with younger age attenuated in the landmark analysis. Compared with breast conserving surgery (BCS) alone, both radiotherapy following BCS and mastectomy were associated with a lower iIBC risk; however, the association for radiotherapy was not evident at the 5‐year landmark. Overall, women with DCIS had a 5.25‐fold higher risk of invasive breast cancer than the general population (95% CI: 4.79, 5.73). Our findings support the importance of long‐term mammographic surveillance, particularly for women with larger DCIS, those treated with BCS, and possibly younger women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
- Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
- Department of Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
- Cancer Epidemiology Unit, Oxford Population Health, University of Oxford, Oxford, UK.
ORCID-Profile: Qian Chen, Sandar Tin Tin
Förderung
- Auckland Medical Research Foundation
- University of Auckland Research Development Fund
Zitieren
APA
Chen, Q., Campbell, I., Elwood, M., Cavadino, A., Aye, P. S., & Tin Tin, S. (2026). Breast Cancer Outcomes From Ductal Carcinoma In Situ: A Population‐Based Cohort Study. International Journal of Cancer, 159(8), 1917-1927. https://doi.org/10.1002/ijc.70559
Vancouver
Chen Q, Campbell I, Elwood M, Cavadino A, Aye PS, Tin Tin S. Breast Cancer Outcomes From Ductal Carcinoma In Situ: A Population‐Based Cohort Study. International Journal of Cancer. 2026;159(8):1917-1927. doi:10.1002/ijc.70559
BibTeX
@article{Chen2026,
author = {Chen, Qian and Campbell, Ian and Elwood, Mark and Cavadino, Alana and Aye, Phyu Sin and Tin Tin, Sandar},
title = {Breast Cancer Outcomes From Ductal Carcinoma In Situ: A Population‐Based Cohort Study},
journal = {International Journal of Cancer},
year = {2026},
volume = {159},
number = {8},
pages = {1917--1927},
doi = {10.1002/ijc.70559}
}
EUVIMED